Planned maintenance: The ODC Business service within the Health Business Services (HBS) portal will be unavailable from 7:00 pm AEST Thursday 23 July 2026 until 7:00 am AEST Friday 24 July 2026. All other services will remain available during this period.
The Government proposes to implement a single medicinal cannabis licence under the Narcotic Drugs Act 1967 (the Act) and other associated reforms to the licence application process. These amendments fall within stage 2 of the Government's reform process and will bring into effect Recommendation 7 from the Review of the Narcotic Drugs Act (the Review).
The Office of Drug Control (ODC) will conduct further face to face consultations on the proposed reforms below - these sessions will provide an opportunity for the ODC to explain in more detail the proposed reforms. Feedback on the proposed amendments will also be sought at this time.
Consultation meetings on the single licence model will be held in Melbourne, Brisbane and Sydney on 30, 31 January and 3 February 2020 respectively, see: Single Licence Model Consultation: Closing date for submissions.